[1] 陈万青,郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床,2015,(13):668-674.
[2] Mosher C E, Sloane R, Morey M C, et al. Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors [J]. Cancer, 2009,115(17):4001-4009.
[3] 杜丽莉,韩存芝,刘秀英,等. 血清瘦素水平及体质指数与乳腺癌发生的相关性研究[J].肿瘤研究与临床, 2006, 18(5):307-310.
[4] 韩存芝,杜丽莉,刘秀英,等. 血清瘦素及脂类水平与乳腺癌的相关性研究[J]. 营养学报, 2005, 27(5): 378-381.
[5] kylin E. Studien uber das Hypertonie-Hyperglykamie-Hyperuri-kamiesyndrome[J]. Zentralblatt Fur Innere Medizin, 1923, 44: 105-127.
[6] Alberti KG, Zimmet P Z. Definitio, diagnosis and classification of diabetes mellitus and its complications. Part1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553.
[7] Borugian M J, Sheps S B. Waist-to-Hip ratio and breast cancer mortality[J]. Am J Epidmiol, 2003, 158 (10): 963-968.
[8] Han C Z , Zhang H T, Du L L, et al. Serum levels of leptin, insulin and lipids in relation to breast cancer in China[J] . Endocine, 2005, 26(1): 19-24.
[9] Kuriyama S, Tsubono Y, Hozawa A, et al . Obesity and risk of cancer in Japan [J]. Int J Cancer, 2005,113 (1): 148-157.
[10] Cleary M P, Phillips F C, Getzin S C,et al . Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors [J]. Breast Cancer Res Treat, 2003, 77 (3):205-215.
[11] Neilson H K, Friedenreich C M, Brockton N T,et al . Physical activity and postmenopausal breast cancer proposed biologic mechanisms and areas for future research [J]. Cancer Epidemid Biomaker Prev, 2009, 18 (1): 11-27.
[12] Spyridopoulos T N, Petridou E T, Skalkidou A, et al. Low adiponectin levels are associated with renal cell carcinoma: a case-control study [J]. Int J Cancer, 2007, 120(7):1573-1578.
[13] 宋桂杭,刘兴荣,赵 越,等. 肥胖与女性乳腺癌预后因素相关性的Meta分析[J]. 肿瘤,2013, 33(12):1074-1080.
[14] Kroenke C H,Chen W Y,Rosner B,et al.Weight,weight gain,and survival after breast cancer diagnosis[J].J Clin Oncol,2005,23(7):1370-1378.
[15] Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe [J]. Int J Cancer, 2001, 91(3): 421-430.
[16] Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J].Nature, 2008, 454(7203): 436-444.
[17] Khandekar M J, Cohen P, Spiegelman B M. Molecular mechanisms of cancer development in obesity[J]. Nat Rev Cancer, 2011, 11(12): 886-895.
[18] Capasso I, Esposito E, Pentimalli F, et al. Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples Experience [J]. J Exp Clin Cancer Res, 2013, 32:14.
[19] Agilli M, Aydin F N, Kurt Y G, et al. Evaluation of leptin, thought as a cancer-related biomarker, in postmenopausal women[J].Cancer Causes and Control, 2015, 26(1): 163-164.
[20] Gong T T, Wu Q J, Wang Y L, et al. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: evidence from a meta-analysis of epidemiologic studies[J]. Int J Cancer, 2015, 137(8): 1967-1978.
[21] Cuello Fredes M, Kato S , Delpiano A M, et al. Leptin promotes a more aggresive behavior of ovarian cancer cells: a potential explanation for a worse prognosis in obese ovarian cancer patients: IGCS-0095 Ovarian Cancer[J]. Int J Gynecol Cancer, 2015, 25(suppl1): 67.
[22] 韩存芝,石 璟,杜丽莉,等. 瘦素及瘦素受体基因多态性与乳腺癌的相关性研究[J]. 中华流行病学杂志,2007,28(2):136-140.
[23] Han C Z, Du L L, Jing J X, et al. Associations among lipids, leptin and leptin receptor gene polymorphisms and breast cancer in China[J]. Biological Trace Element Research, 2008, 126(1-3): 38-48.
[24] 韩存芝,杜丽莉,荆结线,等. 瘦素受体基因变异与乳腺癌发生的关系[J].中华肿瘤杂志,2011, 33(3):207-211.
[25] 王 艳,杜丽莉,韩存芝,等. 瘦素受体基因表达及其多态性与乳腺癌的关系[J]. 肿瘤研究与临床,2015,27(11):740-744.
[26] Noda T, Kikugawa T, Tanji N,et al. Long-term exposure to leptin enhances the growth of prostate cancer cells[J]. Int J Oncol, 2015, 46(4): 1535-1542.
[27] Schmidt S, Monk J M, Robinson L E, et al. The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise [J]. Obesity Reviews, 2015,16(6): 473-487.
[28] Stattin P, Sderberg S, Biessy C, et al. Plasma leptin and breast cancer risk:a prospective study in northern Sweden[J]. Breast Cancer Res Treat, 2004, 86 (3): 191-196.
[29] Avila C, Vazquez-Del Mercado E M, Gomez-Banuelos E, et al. The Impact of LEP G-2548A and LEPR Gln223Arg Polymorphisms on Adiposity, Leptin, and Leptin-Receptor Serum Levels in a Mexican Mestizo Population [J]. Biomed Res Int, 2015, 2015: 339-408.
[30] Li Yingxue, Zhang Qi, Shang Xiaoming, et al. Association of two well-defined polymorphisms in leptin and leptin receptor genes with hypertension and circulating leptin: a meta-analysis [J]. Arch Med Res, 2015, 46 (1):38-46.
[31] Lian Yingdong , Tang Zhijun , Xie Yuxi, et al. Leptin receptor gene polymorphisms and risk of hypertension: a meta-analysis[J]. Int J Clin Exp Med,2015, 8 (8):14277-14282.
[32] Liu Ying , Chen ShuQin , Jing ZhaoHai, et al. Association of LEPR Gln223Arg polymorphism with T2DM: a meta-analysis[J]. Diabetes Res Clin Pract, 2015, 109 (3): e21-26.
[33] Rodrigues P R , Maia L L , Santos M, et al. Leptin receptor expression and Gln223Arg polymorphism as prognostic markers in oral and oropharyngeal cancer[J]. Genet Mol Res, 2015, 14 (4):14979-14988.
[34] Tang H, Zhang Z. Association of leptin receptor gene polymorphisms with genetic susceptibility to ischemic stroke [J]. J Stroke Cerebrovasc Dis, 2015, 24 (9): 2128-2133.
[35] Zhang C , Guo L , Guo X, et al. Interaction of polymorphisms of Leptin receptor gene Gln223Arg, MnSOD9Ala/Val genes and smoking in nonalcoholic fatty liver disease[J]. Wei Sheng Yan Jiu, 2014,43 (5):724-731.
[36] Cleary M P, Phillips F C, Getzin S C, et al. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors[J]. Breast Cancer Res Treat, 2003, 77(3): 205-215.
[37] Cleary M P, Juneja S C, Phillips F C, et al. Leptin receptor-deficient MTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop ncogene-induced mammary tumors[J]. Exp Biol Med, 2004, 229(2): 182-193.
[38] Rose D P, Haffner S M, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women[J]. Endocr Rev, 2007, 28(7): 763-777.
[39] 杜丽莉,郅 洋,韩存芝,等.脂联素对人乳腺癌细胞株T47D细胞周期及凋亡的影响[J].中华微生物学和免疫学杂志, 2012, 32(9):816-819.
[40] Joyce J A, Pollard J W. Microenvironmental regulation of metastasis[J].Nat Rev Cancer,2009,9(4): 239-252.
[41] Falk Libby E, Liu J, Li Y, et al. Globular adiponectin enhances invasion in human breast cancer cells[J]. Oncol Lett, 2016, 11(1): 633-641.
[42] Nelson E R, Wardell S E, Jasper J S, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology [J]. Science, 2013, 342:1094-1098.
[43] Printz C. Researchers find link between high cholesterol and breast cancer [J].Cancer, 2014, 120(22): 3429.
[44] 王瑞珏. 糖尿病乳腺癌和非糖尿病乳腺癌患者临床病例分析[D]. 重庆:重庆医科大学, 2014.
[45] 赵亚婷, 马 杰, 王雅琪, 等. 糖尿病对乳腺癌发生及预后的影响[J].河北医科大学学报, 2018, 39(2): 217-220.
[46] Schrauder M G, Fasching P A, Haberle L, et al. Diabetes and prognosis in a breast cancer cohort[J]. J Cancer Res Clin Oncol, 2011, 137(6): 975-983.
[47] Chen W W, Shao Y Y, Shau W Y, et al. The impact of diabetes mellitus on prognosis on early breast cancer in Asia[J].Oncologist,2012, 17(4): 485-491.
[48] Ushio-Fukai M, Nakamura Y. Reactive oxygen species and an-giogenesis: NADPH oxidase as target for cancer therapy [J]. Cancer Lett, 2008, 266(1): 37-52.
[49] Liu Y, Petreaca M, Martins-Green M. Cell and molecular mechanisms of insulin-induced angiogenesis[J].J Cell Mol Med, 2009, 13(11-12): 4492-4504.